Health Canada said the vaccine was initially approved for use by people 18 years of age and older on December 23, 2020, and then approved for use in children aged 12 to 17 on August 27. year 2021.
Clinical trials have shown that the immune response in children 6 to 11 years of age is comparable to the immune response in people 18 to 25 years of age, supporting the vaccine’s effectiveness in this younger age group. Health Canada said no serious side effects were observed during the trial.
Currently, Health Canada has approved two Covid-19 vaccines, Pfizer and Moderna, for youth (12 to 17 years old) and six for adults (18 years and older), including AstraZeneca, Moderna, Pfizer, Johnson and Johnson, Novavax and Medicago.
Plant-based Medicago was the first vaccine made in Canada, however according to the March 2, 2022 guidance document on the WHO website, it is listed as “not approved” which means It can only be used in Canada.
Source: IANS
